NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) - PAR-25-133
Funder
National Institutes of Health
LOI Required
No
Application Deadline
;
;
;
Maximum Project Duration
5 years
Research Focus Areas
Molecular and Cellular
Pharmacology
Pharmacotherapy
Neurobiology/Neuroscience
Research Methods
Randomized Control Trials (RCT)
Description
The purpose of this Notice of Funding Opportunity (NOFO) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) or biomarker validation studies that may contribute to the justification for and provide the data required for designing future clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests